Respiratory Medicine
Volume 104, Issue 4 , Pages 534-541 , April 2010

Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

  • Brigitta U. Monz

      Affiliations

    • Boehringer Ingelheim GmbH, Binger Strasse 173, D-55216 Ingelheim, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 6132 77 93362; fax: +49 6132 77 4233.
    • ,
  • Paul Sachs

      Affiliations

    • Stamford Hospital, Stamford, 190W. Broad Street, Stamford, CT 06902, United States
    • Columbia University College of Physicians and Surgeons, NY, United States
    • ,
  • Jeffrey McDonald

      Affiliations

    • Mapi Values, 133 Portland Street, Boston, MA 02114, United States
    • ,
  • Bruce Crawford

      Affiliations

    • Mapi Values, Arco Tower 8F, 1-8-1 Shimomeguro, Meguro-ku, Tokyo 153 0064, Japan
    • ,
  • Michael C. Nivens

      Affiliations

    • Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT 06877, United States
    • ,
  • Kay Tetzlaff

      Affiliations

    • Boehringer Ingelheim Pharmaceuticals Inc., 900 Ridgebury Road, Ridgefield, CT 06877, United States
    • Medical Clinic, Department of Sports Medicine, University of Tuebingen, Silcherstrasse 5, D-72076 Tuebingen, Germany

Received 24 November 2008 ,Accepted 31 October 2009.

References 

  1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555
  2. Crawford B, Monz B, Hohlfeld J, et al. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102:1545–1555
  3. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418–1422
  4. Miravitlles M, Murio C, Guerrero T, Gisbert R. DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002;121:1449–1455
  5. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;41:46s–53s
  6. Calverley P, Pauwels R, Lofdahl CG, et al. Relationship between respiratory symptoms and medical treatment in exacerbation of COPD. Eur Respir J. 2005;26:406–413
  7. Leidy NK, Rennard SI, Schmier J, Jones MK, Goldman M. The breathlessness, cough, and sputum scale. The development of empirically based guidelines for interpretation. Chest. 2003;124:2182–2191
  8. Leidy NK, Schmier JK, Jones MK, Lloyd J, Rocchiccioli K. Evaluating symptoms in chronic obstructive pulmonary disease: validation of the breathlessness, cough and sputum scale. Respir Med. 2003;97(Suppl. A):S59–S70
  9. Doll H, Miravittles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Pharmacoeconomics. 2005;23:345–363
  10. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338
  11. Cohen J. Statistical power analysis for the behavioral sciences. Academic Press; 1977;
  12. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–1613
  13. Vijayasaratha K, Stockley RA. Reported and unreported exacerbations of COPD. Chest. 2008;133:34–41
  14. Spencer S, Jones PW GLOBE study group. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax. 2003;58:589–593
  15. Revicki D, Hays RD, Cella D, Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epidemiol. 2008;61(2):102–109
  16. Scanlon PD, Connett JE, Waller LA, Altose MD, Bailey WC, Buist AS. Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The lung health study. Am J Respir Crit Care Med. 2000;161:381–390
  17. Lapperre TS, Sont JK, van Schadewijk A, et al. Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res. 2007;8:85
  18. Moore PL. Practice management and chronic obstructive pulmonary disease in primary care. Am J Med. 2007;120:S23–S27
  19. Tálamo C, de Oca MM, Halbert R, et al. Diagnostic labeling of COPD in five Latin American cities. Chest. 2007;131:60–67
  20. Han MK, Kim MG, Mardon R, et al. Spirometry untilization for COPD. How do we measure up?. Chest. 2007;132:403–409

PII: S0954-6111(09)00361-8

doi: 10.1016/j.rmed.2009.10.026

Respiratory Medicine
Volume 104, Issue 4 , Pages 534-541 , April 2010

Article Tools

* Image Usage & Resolution